CITIUS ONCOLOGY, INC.
Ticker: 1851484
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 |
|---|---|---|---|
| INCOME | |||
| Revenue | 1.49-10.8% | 1.67-57.6% | 3.94 |
| Total Income | 1.49-10.8% | 1.67-57.6% | 3.94 |
| EXPENSES | |||
| Expenditure | 10.21-66.3% | 30.28+229.1% | 9.20 |
| Tax | -0.11+52.2% | -0.23-188.5% | 0.26 |
| PROFIT | |||
| PBT | -9.03+66.4% | -26.84-409.3% | -5.27 |
| Net Profit | -8.92+66.5% | -26.61-381.2% | -5.53 |
| KEY METRICS | |||
| OPM % | -100.00% | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% | -100.00% |
| EPS | -0.08+70.4% | -0.27-350.0% | -0.06 |
Corporate Events
Board MeetingCTOR
202629Sep
Board Meeting
Citius Oncology, Inc. held its 2026 annual meeting of stockh…
SEC Filing ↗ Board MeetingCTOR
202610Aug
Board Meeting
Jonathan Peri appointed as an independent director, expandin…
SEC Filing ↗